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Background: An epidemic of influenza B/Malaysia/2506/2004 was reported in 
Taiwan during the 2006−2007 flu season. We investigated the flu vaccination history 
and clinical and laboratory characteristics of children with influenza B infection.
Methods: We enrolled children younger than 18 years old who visited one of two 
hospitals between November 2006 and February 2007 with influenza-like illnesses. 
Throat swabs were taken on their first visit and cultured for viruses. Complete and 
differential blood counts and blood biochemical parameters were analyzed in some 
children.
Results: Influenza virus was cultured from 51.0% of patients (101/198), 87 (86.1%) of 
who were infected with influenza virus type B. The remaining 14 (13.9%) were infected 
with influenza virus type AH3. The 87 children (median age 7.8 years) with culture-
proven influenza B virus infection were enrolled. Nine parents reported that enrolled 
children had been vaccinated against influenza. Leukopenia was found in 56.1% 
(32/57) of patients, leukocytosis in 3.5% (2/57), and thrombocytopenia in 1.8% (1/57). 
Thirteen of 23 patients (56%) tested for creatine kinase (CK) had elevated levels 
(> 160 U/L), and 11 of 23 (47.8%) had myalgia associated with raised CK (p < 0.05). 
Twenty-six children developed complications, including one case of pneumonia 
with acute respiratory distress syndrome and one case of flu-associated encephalitis.
Conclusion: Most children who contracted influenza B infection had not been vac-
cinated. Almost half the children had leukopenia, and some had leukocytosis, but 
thrombocytopenia was rare. There was a significant association between raised CK 
levels and myalgia in influenza B infection.
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1. Introduction
The influenza virus responsible for the 1918 epidemic 
was extremely virulent and caused many deaths due 
to secondary bacterial pneumonia. Viral pneumonia 
is able to kill previously healthy young individuals 
within 2 days. Every year, 20% of children worldwide 
develop influenza. Children shed virus at higher 
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titers and for longer periods than adults.1 Influenza 
is generally a self-limited respiratory tract illness 
in children, and severe complications have been 
reported in only a few cases. However, influenza-
associated encephalitis and deaths in previously 
healthy children have been increasingly reported.2,3
An island-wide epidemic of influenza B/Malaysia/
2506/2004 was reported in Taiwan during the 2006−
2007 flu season. Many children suffered from high 
spiking fever, general malaise and muscle aches, and 
required medical help. Sixteen cases of influenza 
B associated with complications were reported, 
including five deaths. Four of the five children who 
died were under 18 years old.4 In this study, we 
retrospectively and prospectively enrolled children 
with influenza B infection to investigate the flu 
vaccination history and the clinical and laboratory 
characteristics of flu in children and adolescents.
2. Materials and Methods
Children younger than 18 years of age with influenza-
like illness (ILI) who visited the emergency room 
or outpatient clinic, or who were hospitalized at 
Taichung Veterans General Hospital (TCVGH) or 
Da-Li Jen-Ai Hospital (DLJAH) from November 2006 
to February 2007 were enrolled in this study. ILI 
was defined on the basis of sudden onset of fever 
(> 37.8°C) and any signs or symptoms of acute res-
piratory infection such as cough, sore throat, or a 
runny or stuffy nose.5 A throat swab was taken on 
their first visit and transferred to the laboratory 
for virus culture and immune staining (Chemicon). 
Throat swab specimens were collected and placed 
in transportation medium (Copan), and the medium 
was filtered with a 0.45-μm filter after thorough 
squeezing out of the swab. Two hundred microliters 
of each specimen were inoculated into tubes con-
taining Madin-Darby canine kidney (MDCK) cells and 
Hep-2 cells for influenza and other respiratory virus 
isolation. The tubes were incubated for up to 14 
days to observe any cytopathic effects (CPE). All in-
fluenza isolates were typed using the indirect im-
munofluorescence antibody method (Chemicon). 
A positive CPE was confirmed by typing virally-
infected cells using monoclonal antibodies for in-
fluenza A and B. Influenza virus type A isolates were 
further classified as AH3 or AH1 by multiplex reverse 
transcription-polymerase chain reaction. Patients 
with virus culture-confirmed influenza B infection 
were enrolled for further analysis and study. Blood 
samples were also obtained from some patients.
Laboratory data, including complete and dif-
ferential blood counts (CBC/DC), alanine transami-
nase (ALT), creatine kinase (CK), creatinine and 
C-reactive protein (CRP) were analyzed. CBC/DC 
was performed automatically using a Coulter 
LH750 analyzer (Beckman Coulter, Inc., Fullerton, 
CA, USA). Bio chemical tests were performed using 
Hitachi 7180 and 7600 autoanalyzers (Hitachi High-
Technologies Corporation, Japan). CRP was analyzed 
by immunonephelometry. Leukopenia was defined 
as a white blood count (WBC) < 6000/μL for chil-
dren aged 6 months to 6 years, < 4500/μL for chil-
dren aged 7−12 years, or < 5000/μL for adolescents 
aged 13−18 years.6 Leukocytosis was defined as a 
WBC > 15,000/μL for children aged 6 months to 6 
years, > 13,500/μL for children aged 7−12 years, or 
> 10,000/μL for adolescents aged 13−18 years.6 
Thrombocytopenia was defined as a platelet count 
< 100,000/μL. Thrombo cytosis was defined as a 
platelet count > 400,000/μL. Anemia was defined as 
hemoglobin (Hb) < 12.3 g/dL in males or < 11.3 g/dL 
in females.
After giving informed consent, parents were pro-
spectively or retrospectively requested to complete 
a questionnaire on their first visit, or by chart re-
view and telephone follow-up. The questionnaire 
included questions regarding flu vaccination history 
(how many doses of flu vaccine the patient received, 
flu-like illnesses since they received flu vaccine), 
underlying diseases, and clinical symptoms of flu 
(duration of fever, headache and myalgia).
Children with any infiltrates on chest radiographs 
during the influenza episode were identified, and 
the chest radiographs of these children were reeval-
uated by a radiologist for verification of pneumo-
nia infiltrates. The diagnosis of influenza pneumonia 
was based on simultaneous finding of laboratory-
documented influenza and infiltrates com patible 
with pneumonia on the chest radiograph.7 Influenza- 
associated myositis (IAM)8 was defined as virologically-
proven influenza or influenza-like illness plus clinical 
evidence of localized myalgia, and laboratory evi-
dence of elevated serum CK.
2.1. Statistical analysis
We compared factors associated with flu vaccina-
tion using Fisher’s exact test. The relationships be-
tween myalgia and CK, and influenza B infection 
were analyzed using the χ2 test. A p value < 0.05 
was defined as statistically significant.
3. Results
3.1.  Positive culture rates in patients with 
influenza-like illnesses
A total of 198 throat swab specimens were col-
lected for virus culture from 196 subjects with an 
ILI during the 2006−2007 flu season. The rate of 
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laboratory-confirmed influenza infection was 51.0% 
(101/198) according to cell culture findings (Table 
1). Among patients with positive cultures, 87 (86.1%) 
were infected with influenza virus type B, while 
the remaining 14 (13.9%) were infected with influ-
enza virus type AH3. From the total 198 swabs, 9% 
(18/198) were positive for adenovirus infection, 
1.5% (3/198) for herpes simplex virus (HSV) type 1 
infection, 1.0% (2/198) for nonpolio enterovirus in-
fection, and 0.5% (1/198) for parainfluenza virus 
type 3 infection (Table 1).
3.2. Patient characteristics
A total of 100 children younger than 18 years of age 
with culture-proven influenza A and B virus infec-
tion were enrolled. Their age distribution is shown 
in Figure. Among these, 87 children had culture-
proven influenza B virus infection. Seventy of these 
were treated at TCVGH, and the other 17 subjects 
were treated at DLJAH (age range: 9 months to 
16 years). Most children were between 6 and 9 years 
old. The median age was 7.8 years.
3.3. Vaccination against influenza
Flu vaccination histories were completed by 87.4% 
(76/87) of families (parent or caregiver). The 11 
nonresponses were due to wrong phone numbers 
or unsuccessful contact. In TCVGH, 81.4% (57/70) 
of patients had not received a seasonal influenza 
vaccination, compared with 58.8% (10/17) in DLJAH. 
Ten percent (7/70) of patients in TCVGH and 11.8% 
(2/17) in DLJAH had received a seasonal influenza 
vaccination. We analyzed the relationships between 
age and fever duration, and vaccination against in-
fluenza using Fisher’s exact test. Comparing children 
aged ≤ 6 years and those aged > 6 years, z = 1.10874. 
Comparing fever durations of < 5 days and ≥ 5 days, 
z = −0.5698. There was no significant difference in 
the influenza vaccination rates according to age 
and fever duration (z > −1.96).
3.4. Laboratory analysis
Blood tests were performed in 57 of the 87 patients 
with influenza B infection (49 in TCVGH, 8 in DLJAH). 
The results of CBC/DC, CRP, CK, ALT and creatinine 
were analyzed (Table 2). Leukopenia was found in 
56.1% (32/57) of patients, leukocytosis 3.5% (2/57), 
thrombocytopenia in 1.8% (1/57), thrombocytosis 
in 3.5% (2/57), and anemia in 8.8% (5/57).
Twenty-three patients were tested for CK, and 
13 of them (56.5%) in TCVGH had raised levels 
(> 160 U/L) (Table 2). Eleven of the patients (84.6%) 
with elevated CK levels, compared with only four 
(40%) of the patients with normal CK levels (Table 3) 
had myalgia. One of the 11 patients with IAM was 
a 6-year-old boy who also had rhabdomyolysis. In 
this patient on hospital day 1, CK was elevated to 
17,697 U/L, ALT was 75 U/L, blood urea nitrogen was 
13 mg/dL and creatinine was 0.7 mg/dL. On hospi-
tal day 2, CK was elevated to 21,084 U/L, AST was 
601 U/L and ALT was 154 U/L. On hospital day 4, CK 
was 1132 U/L, AST was 79 U/L and ALT was 104 U/L. 
Variables associated with influenza B infection were 
analyzed by χ2 test. There was a significant associa-
tion between CK > 160 U/L and myalgia in influenza 
B infection (p > 0.05).
3.5. Hospitalization and complications
A total of 31 children with influenza B infection were 
hospitalized, including 22 in TCVGH and 9 in DLJAH. 
Twenty-six children had complication in TCVGH, 
including seven with myositis, one with acute oti-
tis media (AOM), one with acute bronchiolitis, one 
with croup, 16 with pneumonia, one with pneumo-
nia with acute respiratory distress syndrome (ARDS) 
and one with viral encephalitis. Pneumonia was 
diagnosed in 17/87 (19.5%) of our patients, and the 
hospitalization rate was 41.2% (7/17).
4. Discussion
The rate of laboratory-confirmed influenza B in-
fection in our study was 43.7% (87/198), according 
0
10
20
30
40
< 2 3−5 6−9 10−14 > 15
Age (yr)
N
o.
 o
f 
ca
se
s
Influenza A
Influenza B 
Figure Age distribution of patients with influenza A 
and influenza B infection.
Table 1  Culture-positive rate of 198 specimens from 
patients with influenza-like illnesses
Virus Isolation positive rate (%)
Influenza B virus 87/198 (43.9)
Adenovirus 18/198 (9)
Influenza A (H3) virus 14/198 (7)
HSV type 1 3/198 (1.5)
Nonpolio enterovirus 2/198 (1.0)
Parainfluenza virus type 3 1/198 (0.5)
HSV = herpes simplex virus.
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to viral culture findings. Of note, our samples were 
collected from subjects with flu-like illnesses, which 
would be expected to increase the probability of 
influenza virus detection. A previous study that in-
cluded children younger than 36 months present-
ing with fever onset (≥ 38ºC) during the peak of the 
epidemic detected influenza virus in nearly half 
of the febrile children (283/575, 49%).9 Among these, 
253 (89%) were infected with influenza virus type 
A/H3N2, while the remaining 30 (11%) were infected 
with influenza virus type B.
In our study, nine children were infected with 
influenza B despite having received a flu vaccination. 
Since 2004, the Advisory Committee on Immunization 
Practices has recommended that all children aged 
6−23 months should receive two doses of trivalent 
inactivated influenza vaccine.10 Three children aged 
6−23 months received one dose of influenza vac-
cine in our study. The duration of fever was less than 
4 days, except in one patient, who had fever for 
8 days. There were no sequelae in these patients. 
Generally, individuals who are vaccinated against 
influenza should be protected, even though the 
strain coverage of the vaccine may not be fully 
compatible.
The peripheral WBC in influenza B infection can 
be variable, ranging from normal counts to leukocy-
tosis or leukopenia.11 Leukopenia was found in 56.1% 
(32/57) of our patients with influenza B infection, 
12 of who had complications. Nine patients devel-
oped pneumonia, one developed acute bronchiolitis, 
one developed rhabdomyolysis, and five developed 
myositis, but there were no sequelae in these pa-
tients. Joan et al studied the mechanisms behind 
influenza A virus-induced leukopenia, with empha-
sis on the potential induction of apoptosis of lym-
phocytes by the virus.12 Leukocytosis was found in 
3.5% (2/57) of our patients, one of who developed 
pneumonia with ARDS. He was a 14-year-old male 
patient with underlying chronic lung disease post 
tracheostomy. CBC/DC showed a WBC of 27,200/μL, 
Hb of 8.7 g/dL, a platelet count of 327,000/μL, and 
CRP of 2.6 mg/dL on hospital day 1. His pneumonia 
was treated with aqueous penicillin. He also had 
IAM. A finding of leukocytosis should alert clinicians 
to the potential complications of influenza B, such 
Table 3  Relationship between myalgia and CK levels in children with influenza B infection
Myalgia Case number CK > 160 U/L CK < 160 U/L Note
Yes 15 11 (47.8%) 4 (17.4%)
No  8 2 (8.7%) 6 (26.1%)
Total 23 13 10 p < 0.05
CK = creatine kinase.
Table 2 Analysis of laboratory findings in patients with influenza B infection
Test Case number Definition Positive (%)
WBC 57 Leukopenia (WBC < 6000/μL for children aged 32 (56.1)
  6 months to 6 years or WBC < 4500/μL for
  children aged 7−12 years or WBC < 5000/μL 
  for adolescents aged 13−18 years)
 57 Leukocytosis (WBC > 15,000/μL for children aged 2 (3.5)
  6 months to 6 years or WBC > 13,500/μL for
  children aged 7−12 years or WBC > 10,000/μL 
  for adolescent aged 13−18 years)
Platelet 57 Thrombocytosis (platelets > 400,000/μL) 2 (3.5)
 57 Thrombocytopenia (platelets < 100,000/μL) 1 (1.8)
Hb 57 Anemia (Hb < 12.3 g/dL in male or  5 (8.8)
  < 11.3 g/dL in female)
CK 23 Increased (CK > 160 U/L) 13 (56.5)
ALT 43 Increased (ALT > 44 U/L) 9 (20.9)
Creatinine 43 Increased (Creatinine > 1.4 mg/dL) 0 (0)
CRP 57 Increased (CRP > 0.5 mg/dL) 25 (43.9)
ALT = alanine transaminase; CRP = C-reactive protein; CK = creatine kinase; Hb = hemoglobin; WBC = white blood count.
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as secondary bacterial infection or AOM. Secondary 
bacterial pneumonia is most commonly caused 
by Streptococcus pneumoniae or Staphylo coccus 
aureus.7,13 Only one patient in our study had throm-
bocytopenia, which is an uncommon finding in in-
fluenza B infections in children.11
In the current study, IAM occurred in 11 of 23 
(47.8%) patients, including one patient with rhab-
domyolysis. The rate of benign acute childhood my-
ositis in influenza B was reported to be 33.9%.14 
IAM typically occurs in school-aged children, with 
a 2:1 male predominance. Blood CK concentration 
is almost invariably elevated and indicates muscle 
damage. Agyeman et al analyzed 316 cases of IAM.8 
Rhabdomyolysis occurred in 10 of 316 patients (3%), 
was more common in girls (80%), was more often 
associated with influenza A (86%), and led to renal 
failure in eight patients (80%).8 It is thought that 
increased renal vascular resistance secondary to 
increased sympathetic tone, activation of the 
renin-angiotensin axis, increased concentrations of 
vasopressin, or glomerular microthrombi results in 
decreased renal blood flow. Finally, obstruction of 
the renal tubules by myoglobin, protein, or uric acid 
crystals may play a role in the development of acute 
renal failure.15
Although epidemiologic, clinical and laboratory 
data have established a firm link between influenza 
virus infection and IAM, the mechanisms by which 
the virus leads to muscle involvement are poorly un-
derstood. The two most commonly proposed mech-
anisms in the literature are direct muscle invasion 
by viral particles, and immune-mediated muscle 
damage triggered by the virus. The hypothesis of 
direct muscle invasion was supported by the find-
ings of Agyeman et al8 who isolated influenza virus 
from a muscle biopsy specimen in a child with IAM.
Pneumonia was diagnosed in 17/87 (19.5%) of our 
patients. Peltola et al reported that pneumonia 
occurred in 9% of their patients with influenza A or B 
infection,16 and the rate of influenza-related pneu-
monia was estimated to be 14% in a retrospective 
survey of both outpatient and hospitalized children 
with influenza.7 Influenza pneumonia may be under-
estimated, as the illness is difficult to differentiate 
from uncomplicated influenza and other respiratory 
infections, solely on the basis of clinical symptoms.7
Viral encephalitis occurred in a 2.8-year-old boy 
in our study. He was otherwise healthy, though his 
cousin had recently died of influenza B infection 
complicated with myocarditis. The clinical outcome 
was favorable. A national survey in Japan investi-
gated the various parameters of the disease outbreak 
that occurred during the winter of 1998−1999. A total 
of 148 cases were diagnosed as influenza-associated 
encephalitis.3 Of these, 130 (87.8%) were type A 
influenza and 17 were type B. Encephalitis mainly 
developed in children under 5 years. Multiple organ 
failure developed in many patients, and the mor-
tality (31.8%) and morbidity were high. Influenza B 
infections can cause significant mortality and mor-
bidity in immunocompromised children who have 
underlying medical conditions.
In our study, most children who contracted in-
fluenza B infections had not received an influenza 
vaccination during the flu season. Leukopenia was 
found in almost half of the children, while leuko-
cytosis was found in some, but thrombocytopenia 
was uncommon. It is important to recognize the sig-
nificance of the hematologic findings associated with 
influenza B infection. There was a significant as-
sociation between raised CK levels and myalgia in 
children with influenza B infection.
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